companydata.dkcompanydata.dk

Aristo Pharma Nordic ApS: Financial statements 2020

CVR: 32328768

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Aristo Pharma Nordic ApS (CVR 32328768) has filed annual accounts for 2020. In 2020, the company reported a gross profit of EUR 805,029 and a net result of EUR 62,127 compared with EUR -286,054 the year before. That is an increase of 71.4% compared with the year before. Equity in the 2020 report amounted to EUR -1,273,776. The company had 7 employees in the financial year.

Gross Profit
EUR 805,029
Profit/Loss
EUR 62,127
Equity
EUR -1,273,776
Total Assets
EUR 332,045
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-805K EUR62K EUR-1.3M EUR7
2019-470K EUR-286K EUR-1.3M EUR6
2018--949K EUR-1.9M EUR-3M EUR8
2017--3.9M EUR-5M EUR-1.2M EUR10
2016--475K EUR-2.1M EUR-4.7M EUR12

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Aristo Pharma Nordic ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Aristo Pharma Nordic ApS: The 2019 annual report is outSep 3, 2020

Aristo Pharma Nordic ApS has published its annual report for 2019. Gross profit came to DKK 469,744, and the net result was DKK -286,054.

About Aristo Pharma Nordic ApS

Aristo Pharma Nordic ApS is a Danish company of the type Anpartsselskab based in Skovlunde, founded in 2011. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named AMNEAL NORDIC ApS and COPHARMA ApS. The management consists of John Hudson Kriwet. The board consists of John Hudson Kriwet (chair), Jannes Paul Beeskow and Robert Maciej Szymanski. The company is owned by Aristo Pharma GmbH. The company has 1 employee (2026). In 2025, the company reported revenue of EUR 453,392 and a net result of EUR 21,589 compared with EUR 25,190 the year before. Equity in the 2025 report amounted to EUR 184,874.

Source: annual report 2025, Danish Business Authority